Firocoxib sold under the brand names Equioxx and Previcox among others, is a
nonsteroidal anti-inflammatory drug of the
COX-2 inhibitor
COX-2 inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, COX-2, an enzyme responsible for inflammation and pain. Targeting selectivity for COX-2 reduces the risk of peptic ulceration and i ...
(coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox).
Firocoxib is the first COX-2 inhibitor approved by the U.S.
Food and Drug Administration
The United States Food and Drug Administration (FDA or US FDA) is a List of United States federal agencies, federal agency of the United States Department of Health and Human Services, Department of Health and Human Services. The FDA is respon ...
for horses. Firocoxib is not intended or approved for use in human medicine.
Equioxx
, European Medicines Agency
Firocoxib was approved for veterinary use in the United States for dogs in July 2004, and for horses in July 2016. Firocoxib is available as a generic medication for horses and for dogs.
References
External links
*
Dog medications
Equine medications
Furanones
Benzosulfones
COX-2 inhibitors
Nonsteroidal anti-inflammatory drugs
Ethers
Cyclopropyl compounds
{{musculoskeletal-drug-stub